Get started
Author

Alisa B. Lee‐Sherick

Observed names: A B Lee-Sherick, A.B. Lee‐Sherick, Alisa B Lee-Sherick, Alisa B. Lee, Alisa B. Lee-Sherick, Alisa Lee Sherick, Alisa Lee-Sherick
ORCID: 0000-0002-1177-7208
Observed ORCID: 0000-0002-1177-7208
OpenAlex ID: A5072015194
Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia
2015 · Leila Noetzli, Richard W Lo, et al. · Nature Genetics · 330
The unexpected effect of cyclosporin A on CD56+CD16− and CD56+CD16+ natural killer cell subpopulations
2007 · Hongbo Wang, Bartosz Grzywacz, et al. · Blood · 139
PDF
Promoter Specificity and Efficacy in Conditional and Inducible Transgenic Targeting of Lung Macrophages
2017 · Alexandra L. McCubbrey, Kristen C. Allison, et al. · Frontiers in Immunology · 113
PDF
Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
2013 · A B Lee-Sherick, K M Eisenman, et al. · Oncogene · 112
PDF
The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia
2016 · Katherine A. Minson, Catherine C. Smith, et al. · JCI Insight · 81
PDF
UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models
2016 · Deborah DeRyckere, Alisa B. Lee-Sherick, et al. · Clinical Cancer Research · 78
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity
2018 · Alisa B. Lee-Sherick, Kristen M. Jacobsen, et al. · JCI Insight · 71
PDF
Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia
2013 · Rachel M. A. Linger, Alisa B. Lee-Sherick, et al. · Blood · 66
Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia
2015 · Alisa B. Lee-Sherick, Weihe Zhang, et al. · Oncotarget · 45
PDF
Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation
2007 · Alisa B. Lee, Paul Harker‐Murray, et al. · Pediatric Blood & Cancer · 42
Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development
2010 · Alisa B. Lee‐Sherick, Rachel M. A. Linger, et al. · British Journal of Haematology · 38
PDF
Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor Microenvironment
2020 · Jane Koo, Masanori Hayashi, et al. · Frontiers in Oncology · 34
PDF
The small‐molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis
2017 · B.R. Branchford, T.J. Stalker, et al. · Journal of Thrombosis and Haemostasis · 32
Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment
2023 · Joselyn Cruz Cruz, Kristen C. Allison, et al. · Frontiers in Immunology · 28
MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme
2016 · Alexandra Sufit, Alisa B. Lee-Sherick, et al. · PLoS ONE · 27
PDF
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity
2020 · Alisa B. Lee-Sherick, Kristen M. Jacobsen, et al. · JCI Insight · 11
PDF
Erratum: Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
2016 · A B Lee-Sherick, K M Eisenman, et al. · Oncogene · 11
PDF
Serum lactate is associated with increased illness severity in immunocompromised pediatric hematology oncology patients presenting to the emergency department with fever
2022 · Leonora Rose Slatnick, Kristen Miller, et al. · Frontiers in Oncology · 6
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
2013 · Sandra Christoph, Alisa B. Lee-Sherick, et al. · Journal of Visualized Experiments · 6
PDF
MRX2843, a Novel Dual MerTK-FLT3 Inhibitor with Activity Against Resistance-Conferring FLT3 Mutations in Acute Myeloid Leukemia
2014 · Katherine A Minson, Catherine C Smith, et al. · Blood · 4
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
2013 · Sandra Christoph, Alisa B. Lee-Sherick, et al. · Journal of Visualized Experiments · 3
MerTK Receptor Tyrosine Kinase Inhibition As a Potential Strategy to Augment Immune-Mediated Clearance of Acute Myeloid Leukemia
2016 · Lauren Shelby Page, Xiaodong Wang, et al. · Blood · 2
UNC2025, a Small Molecule MerTK and Flt3 Tyrosine Kinase Inhibitor, Decreases Disease Burden, Prolongs Survival, and Promotes Sensitivity to Chemotherapy in Xenograft Models of Acute Leukemia
2014 · Deborah DeRyckere, Alisa B. Lee-Sherick, et al. · Blood · 2
Mer Receptor Tyrosine Kinase Is A Potential Therapeutic Target in Acute Myeloid Leukemia
2012 · Alisa B. Lee-Sherick, Kelly Menachof, et al. · Blood · 2
Mer Receptor Tyrosine Kinase Is Over-Expressed In and Contributes to Oncogenesis In Acute Myeloid Leukemia
2011 · Alisa B. Lee-Sherick, Kristen M. Eisenman, et al. · Blood · 2
Works count: 35
Citation count: 1,290
H-index: 15
I10-index: 17
Year
Topic
Type